Aliases & Classifications for Retinitis

MalaCards integrated aliases for Retinitis:

Name: Retinitis 12 52 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:3612
ICD10 33 H30.9
MeSH 42 D012173
NCIt 47 C115993
UMLS 69 C0035333

Summaries for Retinitis

MalaCards based summary : Retinitis is related to oliver-mcfarlane syndrome and macular dystrophy, patterned, 1. An important gene associated with Retinitis is RPGR (Retinitis Pigmentosa GTPase Regulator), and among its related pathways/superpathways are Development_Thrombopoetin signaling via JAK-STAT pathway and the visual cycle I (vertebrates). The drugs Cidofovir and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and retina, and related phenotypes are Increased HPV16-GFP infection and pigmentation

Wikipedia : 72 Retinitis is inflammation of the retina in the eye, which may lead to blindness. Retinitis may be caused... more...

Related Diseases for Retinitis

Diseases related to Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1403)
id Related Disease Score Top Affiliating Genes
1 oliver-mcfarlane syndrome 32.5 RPGR RPGRIP1
2 macular dystrophy, patterned, 1 32.5 PRPH2 RHO RP9
3 macular degeneration, age-related, 1 32.0 PRPH2 RHO RLBP1 RPE65
4 retinitis pigmentosa 18 32.0 IMPDH1 PRPF3 PRPF31 RP9
5 leber congenital amaurosis 11 31.7 IMPDH1 RHO RP9
6 blessig's cysts 31.3 PRPH2 RPGR
7 leber congenital amaurosis 9 30.0 RPE65 RPGRIP1
8 posterior polar cataract 29.4 RHO RPE65 RPGR
9 retinitis pigmentosa 12.3
10 retinal detachment 12.2
11 retinitis pigmentosa 3 12.1
12 central retinal vein occlusion 12.1
13 retinitis pigmentosa 2 12.1
14 retinitis pigmentosa 9 12.1
15 retinitis pigmentosa 1 12.1
16 central retinal artery occlusion 12.0
17 retinitis pigmentosa 17 12.0
18 retinitis pigmentosa 28 12.0
19 retinal disease 12.0
20 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.0
21 cytomegalovirus retinitis 12.0
22 retinitis pigmentosa 27 12.0
23 infantile cerebellar-retinal degeneration 12.0
24 retinitis pigmentosa-12, autosomal recessive 12.0
25 retinitis pigmentosa 7 and digenic 12.0
26 retinal vasculitis 12.0
27 retinitis pigmentosa 67 12.0
28 retinitis pigmentosa 11 12.0
29 retinitis pigmentosa 41 12.0
30 retinitis pigmentosa 57 12.0
31 retinal degeneration 12.0
32 retinitis pigmentosa 14 12.0
33 retinitis pigmentosa-50 12.0
34 retinitis pigmentosa 38 12.0
35 retinitis pigmentosa 20 12.0
36 retinitis pigmentosa 19 12.0
37 retinitis pigmentosa 35 12.0
38 retinitis pigmentosa 33 12.0
39 retinitis pigmentosa 26 12.0
40 retinitis pigmentosa 4, autosomal dominant or recessive 12.0
41 retinitis pigmentosa 25 12.0
42 retinitis pigmentosa 31 12.0
43 retinitis pigmentosa 13 12.0
44 retinitis pigmentosa 36 12.0
45 retinitis pigmentosa 30 12.0
46 retinitis pigmentosa 23 12.0
47 retinitis pigmentosa 69 11.9
48 branch retinal artery occlusion 11.9
49 retinitis pigmentosa 59 11.9
50 retinitis pigmentosa 58 11.9

Graphical network of the top 20 diseases related to Retinitis:



Diseases related to Retinitis

Symptoms & Phenotypes for Retinitis

GenomeRNAi Phenotypes related to Retinitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased HPV16-GFP infection GR00350-A 8.92 FLVCR1 IMPDH1 RP2 RPE65

MGI Mouse Phenotypes related to Retinitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 pigmentation MP:0001186 9.5 PRPF3 PRPF31 PRPH2 RHO RLBP1 RPE65
2 vision/eye MP:0005391 9.4 RPGRIP1 CERKL PRPF3 PRPF31 PRPH2 RGR

Drugs & Therapeutics for Retinitis

Drugs for Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 236)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 2,Phase 3,Phase 1 113852-37-2 60613
2
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82410-32-0 3454
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1 63585-09-1, 4428-95-9 3415
4
Probenecid Approved Phase 4,Phase 2,Phase 1 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1 4408-78-0 546
6 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1
10 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
11 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
12 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
13 Renal Agents Phase 4,Phase 2,Phase 1
14
Valganciclovir Approved, Investigational Phase 3,Phase 2 175865-60-8 64147
15
Eplerenone Approved Phase 2, Phase 3 107724-20-9 150310 443872
16
Spironolactone Approved Phase 2, Phase 3,Phase 1 1952-01-7, 52-01-7 5833
17
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
18
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
19
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
20
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
21
Pyrimethamine Approved, Vet_approved Phase 3 58-14-0 4993
22
Sulfadiazine Approved, Vet_approved Phase 3 68-35-9 5215
23
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
24
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2,Early Phase 1 59-30-3 6037
25
leucovorin Approved, Nutraceutical Phase 3,Phase 1,Phase 2 58-05-9 143 6006
26
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Phase 1 11103-57-4, 68-26-8 445354
27
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
28 Tocopherol Approved, Nutraceutical Phase 3
29
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
30
B-Carotene Approved, Nutraceutical Phase 2, Phase 3,Phase 1 7235-40-7 5280489
31 diuretics Phase 2, Phase 3,Phase 1
32 Diuretics, Potassium Sparing Phase 2, Phase 3,Phase 1
33 Hormone Antagonists Phase 2, Phase 3, Phase 1
34 Hormones Phase 2, Phase 3, Phase 1
35 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3, Phase 1
36 Mineralocorticoid Receptor Antagonists Phase 2, Phase 3,Phase 1
37 Mineralocorticoids Phase 2, Phase 3,Phase 1
38 Natriuretic Agents Phase 2, Phase 3,Phase 1
39 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
40 Antiemetics Phase 3,Phase 2
41 Anti-Inflammatory Agents Phase 3,Phase 2
42 Antimalarials Phase 3
43 Antineoplastic Agents, Hormonal Phase 3,Phase 2
44 Antiparasitic Agents Phase 3
45 Antiprotozoal Agents Phase 3
46 Autonomic Agents Phase 3,Phase 2,Phase 1
47 BB 1101 Phase 3,Phase 2
48 Clindamycin palmitate Phase 3
49 Clindamycin phosphate Phase 3
50 Dexamethasone acetate Phase 3,Phase 2 1177-87-3

Interventional clinical trials:

(show top 50) (show all 224)

id Name Status NCT ID Phase Drugs
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4 Cidofovir;Probenecid;Ganciclovir
2 The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction Completed NCT00717080 Phase 4
3 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4 Foscarnet sodium
4 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
5 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
6 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3 Valganciclovir
7 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
8 To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis Unknown status NCT00372294 Phase 3 pyrimethamine-sulfadiazine + prednisolone;Clindamycin+Dexamethasone
9 Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A Completed NCT00346333 Phase 3 Lutein
10 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3 Cidofovir
11 Randomized Trial for Retinitis Pigmentosa Completed NCT00000116 Phase 3 Vitamin A;Nutritional Supplement
12 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3 Ganciclovir
13 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3 Ganciclovir
14 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3 Foscarnet;Ganciclovir
15 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3 MSL-109
16 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3 Sargramostim;Ganciclovir
17 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3 Cidofovir intravenous
18 Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa Completed NCT00000114 Phase 3 Vitamin E;Vitamin A
19 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3 Ganciclovir;Foscarnet
20 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
21 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3 Valganciclovir;Ganciclovir
22 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3 Valganciclovir;Acyclovir
23 Ozurdex for Macular Edema Post Membrane Peeling Completed NCT01273727 Phase 2, Phase 3 Dexamethasone;dexamethasone
24 Laser and Medical Treatment of Diabetic Macular Edema Completed NCT00050479 Phase 3 Celecoxib (Celebrex)
25 The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil Recruiting NCT01680510 Phase 2, Phase 3
26 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
27 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Not yet recruiting NCT03184584 Phase 2, Phase 3 PBI-4050
28 Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa Terminated NCT01786395 Phase 3 UF-021;Placebo
29 Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Unknown status NCT01914913 Phase 1, Phase 2
30 A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) Unknown status NCT02110225 Phase 1, Phase 2 rhNGF 60 µg/ml eye drops solution;rhNGF 180 µg/ml eye drops solution;Placebo
31 Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Completed NCT01560715 Phase 2
32 Trial of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01233609 Phase 2 Valproic Acid;Placebo
33 A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Completed NCT00447993 Phase 2 NT-501;NT-501
34 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2 Foscarnet sodium;Ganciclovir
35 Safety Study in Retinal Transplantation for Retinitis Pigmentosa. Completed NCT00345917 Phase 2
36 A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Completed NCT00447980 Phase 2 NT-501;NT-501
37 Effects of Lutein in Retinitis Pigmentosa Completed NCT00029289 Phase 1, Phase 2 Lutein (10 or 30 mg/day) capsules
38 Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa Completed NCT02140164 Phase 1, Phase 2 Minocycline
39 Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa Completed NCT02320812 Phase 1, Phase 2
40 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2 Fomivirsen sodium;Ganciclovir
41 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2 Nelfinavir mesylate
42 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2 Foscarnet sodium
43 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Completed NCT02609165 Phase 2 rhNGF 180 µg/ml eye drops solution;vehicle eye drops
44 DHA and X-Linked Retinitis Pigmentosa Completed NCT00100230 Phase 2 docosahexaenoic acid OR corn/soy oil placebo
45 An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa Completed NCT00661479 Phase 1, Phase 2 400 µg Brimonidine Tartrate Implant;200 µg Brimonidine Tartrate Implant;100 µg Brimonidine Tartrate Implant
46 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Completed NCT00004794 Phase 2 cidofovir
47 The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Completed NCT00002356 Phase 2 Fomivirsen sodium
48 The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Completed NCT00002437 Phase 2 Cidofovir;Probenecid
49 Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS Completed NCT00001061 Phase 2 Sevirumab;Foscarnet sodium;Ganciclovir
50 Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01399515 Phase 2 Valproic Acid

Search NIH Clinical Center for Retinitis

Genetic Tests for Retinitis

Anatomical Context for Retinitis

MalaCards organs/tissues related to Retinitis:

39
Eye, Endothelial, Retina, Bone, Testes, T Cells, Brain

Publications for Retinitis

Articles related to Retinitis:

(show top 50) (show all 11990)
id Title Authors Year
1
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study. ( 28807635 )
2017
2
Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report. ( 28724375 )
2017
3
Repair of Total Tractional Retinal Detachment in Norrie Disease: Report of Technique and Successful Surgical Outcome. ( 28297040 )
2017
4
Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models. ( 28814713 )
2017
5
Mutations in the PCYT1A gene are responsible for isolated forms of retinal dystrophy. ( 28272537 )
2017
6
Internal Repair of Very Large, Myopic and Recurrent Macular Holes by Creation of a Central Retinal Detachment and Silicone Oil Tamponade. ( 28858063 )
2017
7
Proteomic Analysis of Elevated Intraocular Pressure with Retinal Detachment. ( 28825049 )
2017
8
RETINAL CAPILLARY DENSITY IN PATIENTS WITH BIRDSHOT CHORIORETINOPATHY. ( 28196058 )
2017
9
A Report on Molecular Diagnostic Testing for Inherited Retinal Dystrophies by Targeted Genetic Analyses. ( 28005406 )
2017
10
Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion. ( 28085526 )
2017
11
Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature. ( 28603574 )
2017
12
CONN SYNDROME PRESENTING AS CENTRAL RETINAL VEIN OCCLUSION. ( 28644176 )
2017
13
The Penumbra Obscura Stimulates Iris Neovascularisation after Isolated Central Retinal Artery Occlusion. ( 28367049 )
2017
14
Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration. ( 28939808 )
2017
15
Retinitis Pigmentosa Associated with Glucose-6-Phosphate Dehydrogenase Deficiency. ( 28948126 )
2017
16
Identification of a disease-causing mutation in a Chinese patient with retinitis pigmentosa by targeted next-generation sequencing. ( 28430325 )
2017
17
Whole exome sequencing identified a novel single base pair insertion mutation in the EYS gene in a six generation family with retinitis pigmentosa. ( 28419563 )
2017
18
Type 3 Neovascularization Associated with Retinitis Pigmentosa. ( 28512428 )
2017
19
Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa. ( 28523457 )
2017
20
OCT Angiography: Assessment of Retinal Ischemia in Susac's Syndrome. ( 28613358 )
2017
21
Cytomegalovirus retinitis in Cape Town, South Africa: Clinical management and outcomes. ( 28604324 )
2017
22
Swept-Source Optical Coherence Tomography Angiography in West Nile Virus Chorioretinitis and Associated Occlusive Retinal Vasculitis. ( 28810044 )
2017
23
Cofactors associated with Sudden Acquired Retinal Degeneration Syndrome: 151 dogs within a reference population. ( 28845542 )
2017
24
Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study. ( 28865424 )
2017
25
Systemic intravenous abciximab: a novel treatment for acute central retinal artery occlusion? ( 28470954 )
2017
26
Case of combination therapy to treat lupus retinal vasculitis refractory to steroids. ( 28237161 )
2017
27
Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. ( 28689169 )
2017
28
Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. ( 28636406 )
2017
29
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease. ( 28041643 )
2017
30
Neuroprotective effects of a novel peptide, FK18, under oxygen-glucose deprivation in SH-SY5Y cells and retinal ischemia in ratsA viaA the Akt pathway. ( 28257830 )
2017
31
A Novel Dominant Mutation in SAG, the Arrestin-1 Gene, Is a Common Cause of Retinitis Pigmentosa in Hispanic Families in the Southwestern United States. ( 28549094 )
2017
32
Transient central retinal artery occlusion after sub-tenon's anaesthesia: Is it a safe technique? ( 28755793 )
2017
33
OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study. ( 28145973 )
2017
34
A New Complication Associated with the Use of Prophylactic Intracameral Antibiotics: Hemorrhagic Occlusive Retinal Vasculitis. ( 28433121 )
2017
35
Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'. ( 28840855 )
2017
36
Long-term rearrangement of retinal structures in a novel mutation of X-linked retinoschisis. ( 28811895 )
2017
37
Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice. ( 28210901 )
2017
38
RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. ( 28902097 )
2017
39
NOVEL CLASSIFICATION SYSTEM FOR COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM. ( 28098730 )
2017
40
A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model. ( 28803066 )
2017
41
Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs. ( 28924438 )
2017
42
Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy. ( 28490649 )
2017
43
Absence of Sigma 1 Receptor Accelerates Photoreceptor Cell Death in a Murine Model of Retinitis Pigmentosa. ( 28877319 )
2017
44
The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture. ( 28152535 )
2017
45
Perioptic neuritis related with varicella-zoster virus infection preceding sixth cranial nerve palsy and progressive outer retinal necrosis in a immunocompetent patient. ( 28131177 )
2017
46
The unusual association of inverse retinitis pigmentosa and Fuchs' heterochromic iridocyclitis. ( 28127443 )
2017
47
Retinal slippage fold causing a matching contralateral scotoma. ( 28395868 )
2017
48
Optical Coherence Tomography Angiography of a Central Retinal Artery Occlusion Before and After Anterior Chamber Paracentesis. ( 28433123 )
2017
49
Foveal thinning in neuromyelitis optica: A sign of retinal astrocytopathy? ( 28439528 )
2017
50
Protective effect of sulforaphane against retinal degeneration in the Pde6(rd10) mouse model of retinitis pigmentosa. ( 28937835 )
2017

Variations for Retinitis

Expression for Retinitis

Search GEO for disease gene expression data for Retinitis.

Pathways for Retinitis

Pathways related to Retinitis according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.69 RHO RLBP1 RPE65
2
Show member pathways
10.54 RHO RLBP1 RPE65
3 9.91 RGR RHO

GO Terms for Retinitis

Cellular components related to Retinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cilium GO:0005929 9.56 RP1 RP2 RPGR RPGRIP1
2 spliceosomal complex GO:0005681 9.5 PRPF3 PRPF31 SNRNP200
3 photoreceptor inner segment GO:0001917 9.33 CERKL RHO RP1
4 U4/U6 x U5 tri-snRNP complex GO:0046540 9.13 PRPF3 PRPF31 SNRNP200
5 photoreceptor outer segment GO:0001750 9.02 CERKL PRPH2 RHO RP1 RPGR

Biological processes related to Retinitis according to GeneCards Suite gene sharing:

(show all 14)
id Name GO ID Score Top Affiliating Genes
1 RNA splicing GO:0008380 9.78 PRPF3 PRPF31 RP9 SNRNP200
2 response to stimulus GO:0050896 9.76 EYS RGR RHO RLBP1 RP1 RPE65
3 phototransduction GO:0007602 9.54 RGR RHO
4 retinoid metabolic process GO:0001523 9.54 RHO RLBP1 RPE65
5 response to light stimulus GO:0009416 9.52 RHO RPE65
6 detection of light stimulus involved in visual perception GO:0050908 9.51 EYS RPE65
7 protein-chromophore linkage GO:0018298 9.49 RGR RHO
8 spliceosomal tri-snRNP complex assembly GO:0000244 9.46 PRPF3 PRPF31
9 retina morphogenesis in camera-type eye GO:0060042 9.43 RP1 RPE65
10 phototransduction, visible light GO:0007603 9.4 RHO RP1
11 retina development in camera-type eye GO:0060041 9.35 PRPH2 RHO RP1 RPE65 RPGRIP1
12 vitamin A metabolic process GO:0006776 9.32 RLBP1 RPE65
13 visual perception GO:0007601 9.32 EYS PRPH2 RGR RHO RLBP1 RP1
14 cellular response to light stimulus GO:0071482 9.26 RHO RP1

Molecular functions related to Retinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 photoreceptor activity GO:0009881 8.62 RGR RHO

Sources for Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....